BCL2L1 and lung carcinoma: Niclosamide not only blocked the activation of the STAT3/Bcl-2/BCL-xl pathway induced by ionizing radiation in both radiosensitive and radioresistant human lung cancer cells but also overcame acquired radioresistance in vitro and in vivo11.